- Home
- SURG vs INKT Comparison
SURG vs INKT Comparison
Compare SURG & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- INKT
- Stock Information
- Founded
- SURG 2006
- INKT 2017
- Country
- SURG United States
- INKT United States
- Employees
- SURG N/A
- INKT N/A
- Industry
- SURG Advertising
- INKT Medicinal Chemicals and Botanical Products
- Sector
- SURG Consumer Discretionary
- INKT Health Care
- Exchange
- SURG Nasdaq
- INKT Nasdaq
- Market Cap
- SURG 27.0M
- INKT 31.2M
- IPO Year
- SURG N/A
- INKT 2021
- Fundamental
- Price
- SURG $2.80
- INKT $7.03
- Analyst Decision
- SURG Strong Buy
- INKT Strong Buy
- Analyst Count
- SURG 1
- INKT 2
- Target Price
- SURG $8.75
- INKT $37.50
- AVG Volume (30 Days)
- SURG 283.6K
- INKT 2.8K
- Earning Date
- SURG 05-20-2025
- INKT 05-15-2025
- Dividend Yield
- SURG N/A
- INKT N/A
- EPS Growth
- SURG N/A
- INKT N/A
- EPS
- SURG N/A
- INKT N/A
- Revenue
- SURG $60,881,173.00
- INKT N/A
- Revenue This Year
- SURG $59.57
- INKT N/A
- Revenue Next Year
- SURG $75.47
- INKT N/A
- P/E Ratio
- SURG N/A
- INKT N/A
- Revenue Growth
- SURG N/A
- INKT N/A
- 52 Week Low
- SURG $1.05
- INKT $4.56
- 52 Week High
- SURG $4.38
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- SURG 57.49
- INKT 39.71
- Support Level
- SURG $2.56
- INKT $7.20
- Resistance Level
- SURG $3.47
- INKT $7.40
- Average True Range (ATR)
- SURG 0.27
- INKT 0.39
- MACD
- SURG -0.06
- INKT -0.02
- Stochastic Oscillator
- SURG 33.00
- INKT 27.41
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.